Stanford Mice With Human Brain Cells Could Cure Dementia

Scientists just solved one of medicine's biggest challenges: how to study human brain diseases without access to living human brains.

Researchers at Stanford University created mice with brains made up of more than 90 percent human neurons. The tiny animals look normal on the outside, but inside their skulls, human brain cells have taken over and are now firing away, creating a living laboratory for studying conditions that have stumped doctors for decades.

The team, led by neuroscientist Sergiu Pașca, first genetically modified newborn mice so they wouldn't grow their cortex, the brain's outer layer responsible for movement and decision making. Then they injected lab-grown human brain cells into the empty spaces.

Within three months, the human cells had multiplied and integrated themselves into the mice's neural wiring. The animals behaved normally, showing no signs of distress or disability.

The Ripple Effect

This breakthrough could transform treatment for millions of people suffering from brain disorders. The human tissue in these mice developed into specialized cells called von Economo neurons, which die first in patients with frontotemporal dementia but couldn't be grown in labs before.

Pașca's team already discovered that these mice accurately model cerebral palsy. When they exposed the human brain tissue to low oxygen, the mice developed motor coordination problems identical to those seen in humans with the condition. Regular mice don't respond to oxygen deprivation the same way humans do, making them poor models for study.

The research also offers new hope for understanding autism, schizophrenia and epilepsy. Human brains contain 86 billion neurons with trillions of connections, making them extraordinarily complex. Scientists have had almost no way to watch how diseases develop or test new treatments in real time.

The Stanford team worked closely with bioethicists throughout the project, designing safeguards to address concerns about consciousness and pain. They added the human tissue only after the mouse brains had already developed, ensuring the animals maintained their normal mouse awareness.

Pașca now plans to use these mice to investigate why certain brain cells die in dementia patients. "We're trying to see whether mutations associated with frontotemporal dementia are making these cells uniquely susceptible to disease," he explained.

After more than a decade of working with brain organoids, tiny replicas grown from human skin cells, researchers finally have a tool that mimics human brain development closely enough to unlock real answers.